Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson's Disease and Parkinsonism”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01399905
What this trial is testing

High and Low Dose Carbidopa Treatment of Parkinson's Disease

Who this might be right for
Parkinson's Disease
Oregon Health and Science University 14
Not applicableStudy completedNCT00024622
What this trial is testing

PET Scanning in Parkinson s Disease

Who this might be right for
SchizophreniaParkinson's Disease
National Institute of Mental Health (NIMH) 502
Large-scale testing (Phase 3)Study completedNCT00056524
What this trial is testing

Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)

Who this might be right for
Alzheimer's DiseaseStrokeParkinson's Disease+1 more
Avanir Pharmaceuticals 600
Large-scale testing (Phase 3)Study completedNCT02172573
What this trial is testing

Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 315
Testing effectiveness (Phase 2)Study completedNCT00529724
What this trial is testing

Body Weight Gain, Parkinson, Subthalamic Stimulation

Who this might be right for
Parkinson's Disease
University Hospital, Clermont-Ferrand 34
Testing effectiveness (Phase 2)Study completedNCT01759888
What this trial is testing

Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism

Who this might be right for
Parkinson's Disease
Chang Gung Memorial Hospital 49
Early research (Phase 1)Study completedNCT02772627
What this trial is testing

Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202

Who this might be right for
Parkinson's Disease
Bial - Portela C S.A. 22
Not applicableLooking for participantsNCT07207122
What this trial is testing

Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease

Who this might be right for
Parkinson Disease
Sanmai Technologies PBC dba Sanmai 60
Not applicableNot Yet RecruitingNCT07494461
What this trial is testing

Inhibitory Control and Gait Adaptability in Parkinson's Disease

Who this might be right for
Parkinson Disease (PD)
National Yang Ming Chiao Tung University 50
Early research (Phase 1)Study completedNCT06004180
What this trial is testing

A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD)

Who this might be right for
Parkinson Disease
H. Lundbeck A/S 6
Testing effectiveness (Phase 2)UnknownNCT01860794
What this trial is testing

Evaluation of Safety and Tolerability of Fetal Mesencephalic Dopamine Neuronal Precursor Cells for Parkinson's Disease

Who this might be right for
Idiopathic Parkinson DiseasePrimary Parkinsonism
Bundang CHA Hospital 15
Not applicableStudy completedNCT03905954
What this trial is testing

The Impact of a Diagnosis of Parkinson's on Work

Who this might be right for
Parkinson Disease
Oxford Brookes University 696
Testing effectiveness (Phase 2)Study completedNCT02640729
What this trial is testing

Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia

Who this might be right for
Lewy Body DementiaVisual Hallucinations
Axovant Sciences Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT00013624
What this trial is testing

Riluzole to Treat Parkinson's Disease

Who this might be right for
Parkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS) 20
Early research (Phase 1)Study completedNCT02169466
What this trial is testing

Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Benserazide

Who this might be right for
Parkinson's Disease (PD)
Bial - Portela C S.A. 22
Large-scale testing (Phase 3)Study completedNCT02601586
What this trial is testing

Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease

Who this might be right for
Parkinson Disease
University Hospital, Toulouse 67
Not applicableUnknownNCT06225869
What this trial is testing

Effect of Dopamine on Specific Processing of Shame and Embarrassment in Parkinson's Disease

Who this might be right for
Parkinson Disease
University Hospital, Geneva 30
Not applicableActive Not RecruitingNCT05043103
What this trial is testing

Long-Term Observational Study on Effectiveness and Safety of Lecigon in Patients With Advanced Parkinson's Disease

Who this might be right for
Advanced Parkinson Disease
Britannia Pharmaceuticals Ltd. 312
Early research (Phase 1)Study completedNCT02169427
What this trial is testing

An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 9-1067 and Metabolites

Who this might be right for
Parkinson's Disease (PD)
Bial - Portela C S.A. 6
Not applicableUnknownNCT04189042
What this trial is testing

Figure-of-Eight Walk Test in Parkinson

Who this might be right for
Parkinson Disease
Gazi University 30
Next Page